Earnings History Data for Vaxcyte, Inc. (PCVX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Vaxcyte, Inc.
Vaxcyte Inc.is a biopharmaceutical company develops vaccines for infectious diseases. It offers conjugate, pneumococcal conjugate and complex antigen-based vaccines. Vaxcyte Inc.is based in Foster City, California.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 08-05-2024 | AH | PCVX | Vaxcyte | 7,198 | -0.85 | -1.11 | 0.00 | Vaxcyte GAAP EPS of -$0.85 [5/9/2024 12:46 PM] |
65.36 | -1.43 (-2.14%) |
66.79 | 0.0 (0.00%) |
44.20 - 82.04 | 722,302 | 650,000 | 23,718 | ||
| 27-02-2024 | AH | PCVX | Vaxcyte, Inc. | 7,310 | -1.82 | -0.89 | -0.73 | Vaxcyte GAAP EPS of -$4.14 misses by $0.65 [2/27/2024 4:05 PM] |
75.10 | -5.95 (-7.34%) |
78.86 | -2.19 (-2.70%) |
34.11 - 82.04 | 1,188,939 | 830,000 | 33,511 | ||
| 27-02-2023 | AH | 4:10 PM ET (Feb 27) |
PCVX | Vaxcyte, Inc. | 3,400 | -0.73 | -0.84 | -0.54 | Vaxcyte GAAP EPS of -$3.44 misses by $0.11 [2/27/2023 4:14 PM] |
41.03 | -1.27 (-3.00%) |
42.30 | 0.0 (0.00%) |
17.44 - 49.31 | 878,876 | 520,000 | 27,147 | |
| 07-11-2022 | AH | PCVX | Vaxcyte | 2,659 | -0.93 | -0.80 | 0.00 | Vaxcyte GAAP EPS of -$0.93 misses by $0.09 [11/7/2022 5:15 PM] |
44.73 | 1.38 (3.19%) |
42.40 | -0.95 (-2.19%) |
16.78 - 46.03 | 1,146,739 | 2,950,000 | 232 | ||
| 08-08-2022 | AH | 4:10 PM ET (Aug 8) |
PCVX | Vaxcyte | 1,494 | -0.80 | -0.69 | 0.00 | Vaxcyte reports Q2 results [8/8/2022 5:52 PM] |
25.93 | 0.01 (0.04%) |
25.92 | 0.0 (0.00%) |
16.78 - 27.44 | 318,536 | 320,000 | 10,018 | |
| 09-05-2022 | AH | 4:10 PM ET (May 9) |
PCVX | Vaxcyte | 1,426 | -0.68 | -0.56 | 0.00 | Vaxcyte GAAP EPS of -$0.68 misses by $0.05 [5/9/2022 5:25 PM] |
21.76 | 0.35 (1.66%) |
23.95 | -0.32 (-1.32%) |
15.51 - 27.44 | 411,130 | 268,843 | 1 | |
| 28-02-2022 | AH | 4:10 PM ET (Feb 28) |
PCVX | Vaxcyte, Inc. | 1,190 | -0.54 | -0.46 | -0.41 | Vaxcyte GAAP EPS of -$1.93 [2/28/2022 4:41 PM] |
23.87 | 0.70 (3.02%) |
23.17 | 0.0 (0.00%) |
15.51 - 28.30 | 330,541 | 250,000 | 3,362 | |
| 10-11-2021 | AH | PCVX | Vaxcyte | 1,300 | -0.51 | -0.47 | 0.00 | Vaxcyte EPS beats by $0.04 [11/10/2021 5:16 PM] |
25.70 | 1.03 (4.18%) |
24.67 | 0.0 (0.00%) |
15.51 - 38.69 | 34,522 | 110,000 | 2,354 | ||
| 11-05-2021 | AH | 4:10 PM ET (May 11) |
PCVX | Vaxcyte, Inc. | 906.00 | -0.41 | -0.41 | 0.00 | Vaxcyte EPS beats by $0.10 [5/11/2021 4:42 PM] |
18.72 | 1.38 (7.96%) |
17.34 | 0.0 (0.00%) |
15.51 - 58.48 | 203,017 | 190,000 | 965 | |
|
||||||||||||||||||
| 29-03-2021 | AH | 4:15 PM ET (Mar 29) |
PCVX | Vaxcyte, Inc. | 1,250 | -0.41 | -0.48 | 0.00 | Vaxcyte EPS beats by $0.12 [3/29/2021 4:19 PM] |
18.49 | -4.24 (-18.65%) |
19.00 | -3.73 (-16.41%) |
17.80 - 58.48 | 1,130,310 | 660,000 | 9,430 | |